Logo image of NICE

NICE LTD - SPON ADR (NICE) Stock Fundamental Analysis

NASDAQ:NICE - Nasdaq - US6536561086 - ADR - Currency: USD

157.39  +1.35 (+0.87%)

After market: 157.39 0 (0%)

Fundamental Rating

6

Overall NICE gets a fundamental rating of 6 out of 10. We evaluated NICE against 281 industry peers in the Software industry. While NICE has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on NICE. These ratings would make NICE suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year NICE was profitable.
In the past year NICE had a positive cash flow from operations.
Each year in the past 5 years NICE has been profitable.
NICE had a positive operating cash flow in each of the past 5 years.
NICE Yearly Net Income VS EBIT VS OCF VS FCFNICE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

NICE has a better Return On Assets (8.36%) than 82.92% of its industry peers.
NICE's Return On Equity of 12.33% is fine compared to the rest of the industry. NICE outperforms 79.36% of its industry peers.
NICE has a better Return On Invested Capital (10.53%) than 86.83% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NICE is below the industry average of 12.03%.
The 3 year average ROIC (8.49%) for NICE is below the current ROIC(10.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.36%
ROE 12.33%
ROIC 10.53%
ROA(3y)6.8%
ROA(5y)5.86%
ROE(3y)10.37%
ROE(5y)9.17%
ROIC(3y)8.49%
ROIC(5y)7.35%
NICE Yearly ROA, ROE, ROICNICE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

NICE has a Profit Margin of 16.18%. This is amongst the best in the industry. NICE outperforms 80.43% of its industry peers.
In the last couple of years the Profit Margin of NICE has grown nicely.
The Operating Margin of NICE (20.01%) is better than 87.90% of its industry peers.
NICE's Operating Margin has improved in the last couple of years.
NICE's Gross Margin of 66.75% is in line compared to the rest of the industry. NICE outperforms 49.82% of its industry peers.
NICE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.01%
PM (TTM) 16.18%
GM 66.75%
OM growth 3Y13.2%
OM growth 5Y5.69%
PM growth 3Y15.92%
PM growth 5Y6.5%
GM growth 3Y-0.37%
GM growth 5Y0.16%
NICE Yearly Profit, Operating, Gross MarginsNICE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

NICE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for NICE remains at a similar level compared to 1 year ago.
NICE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NICE has been reduced compared to a year ago.
NICE Yearly Shares OutstandingNICE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NICE Yearly Total Debt VS Total AssetsNICE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

There is no outstanding debt for NICE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.63
Altman-Z N/A
ROIC/WACC1.18
WACC8.92%
NICE Yearly LT Debt VS Equity VS FCFNICE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.70 indicates that NICE should not have too much problems paying its short term obligations.
With a Current ratio value of 1.70, NICE perfoms like the industry average, outperforming 51.96% of the companies in the same industry.
A Quick Ratio of 1.70 indicates that NICE should not have too much problems paying its short term obligations.
NICE's Quick ratio of 1.70 is in line compared to the rest of the industry. NICE outperforms 52.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
NICE Yearly Current Assets VS Current LiabilitesNICE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

6

3. Growth

3.1 Past

NICE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.51%, which is quite impressive.
NICE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.93% yearly.
NICE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.05%.
The Revenue has been growing by 11.69% on average over the past years. This is quite good.
EPS 1Y (TTM)26.51%
EPS 3Y19.48%
EPS 5Y15.93%
EPS Q2Q%27.97%
Revenue 1Y (TTM)15.05%
Revenue growth 3Y12.5%
Revenue growth 5Y11.69%
Sales Q2Q%15.79%

3.2 Future

NICE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.77% yearly.
Based on estimates for the next years, NICE will show a quite strong growth in Revenue. The Revenue will grow by 8.25% on average per year.
EPS Next Y12.13%
EPS Next 2Y10.63%
EPS Next 3Y10.77%
EPS Next 5YN/A
Revenue Next Year7.07%
Revenue Next 2Y7.14%
Revenue Next 3Y8.25%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NICE Yearly Revenue VS EstimatesNICE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
NICE Yearly EPS VS EstimatesNICE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

NICE is valuated correctly with a Price/Earnings ratio of 13.73.
Based on the Price/Earnings ratio, NICE is valued cheaply inside the industry as 86.83% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.22, NICE is valued rather cheaply.
The Price/Forward Earnings ratio is 12.25, which indicates a correct valuation of NICE.
Based on the Price/Forward Earnings ratio, NICE is valued cheaper than 89.68% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.86, NICE is valued a bit cheaper.
Industry RankSector Rank
PE 13.73
Fwd PE 12.25
NICE Price Earnings VS Forward Price EarningsNICE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NICE is valued cheaper than 91.81% of the companies in the same industry.
90.04% of the companies in the same industry are more expensive than NICE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.5
EV/EBITDA 9.98
NICE Per share dataNICE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of NICE may justify a higher PE ratio.
PEG (NY)1.13
PEG (5Y)0.86
EPS Next 2Y10.63%
EPS Next 3Y10.77%

0

5. Dividend

5.1 Amount

No dividends for NICE!.
Industry RankSector Rank
Dividend Yield N/A

NICE LTD - SPON ADR

NASDAQ:NICE (5/2/2025, 8:13:04 PM)

After market: 157.39 0 (0%)

157.39

+1.35 (+0.87%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-20 2025-02-20/dmh
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners13.41%
Inst Owner Change-0.11%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.89B
Analysts81.25
Price Target199.67 (26.86%)
Short Float %2.77%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.54%
Min EPS beat(2)-0.07%
Max EPS beat(2)5.16%
EPS beat(4)3
Avg EPS beat(4)2.18%
Min EPS beat(4)-0.07%
Max EPS beat(4)5.16%
EPS beat(8)7
Avg EPS beat(8)2.03%
EPS beat(12)11
Avg EPS beat(12)2.24%
EPS beat(16)14
Avg EPS beat(16)2.14%
Revenue beat(2)0
Avg Revenue beat(2)-1.2%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)-1.15%
Revenue beat(4)0
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)-1.15%
Revenue beat(8)0
Avg Revenue beat(8)-1.24%
Revenue beat(12)1
Avg Revenue beat(12)-1.03%
Revenue beat(16)3
Avg Revenue beat(16)-0.46%
PT rev (1m)-0.36%
PT rev (3m)-19.43%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-1.38%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)0.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.85%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-2.87%
Valuation
Industry RankSector Rank
PE 13.73
Fwd PE 12.25
P/S 3.62
P/FCF 13.5
P/OCF 11.88
P/B 2.76
P/tB 6.56
EV/EBITDA 9.98
EPS(TTM)11.46
EY7.28%
EPS(NY)12.85
Fwd EY8.17%
FCF(TTM)11.66
FCFY7.41%
OCF(TTM)13.24
OCFY8.41%
SpS43.51
BVpS57.1
TBVpS24
PEG (NY)1.13
PEG (5Y)0.86
Profitability
Industry RankSector Rank
ROA 8.36%
ROE 12.33%
ROCE 14.32%
ROIC 10.53%
ROICexc 18.29%
ROICexgc 338.87%
OM 20.01%
PM (TTM) 16.18%
GM 66.75%
FCFM 26.79%
ROA(3y)6.8%
ROA(5y)5.86%
ROE(3y)10.37%
ROE(5y)9.17%
ROIC(3y)8.49%
ROIC(5y)7.35%
ROICexc(3y)14.21%
ROICexc(5y)12.54%
ROICexgc(3y)163.2%
ROICexgc(5y)N/A
ROCE(3y)11.54%
ROCE(5y)10%
ROICexcg growth 3Y25.61%
ROICexcg growth 5Y53.42%
ROICexc growth 3Y23.7%
ROICexc growth 5Y18.36%
OM growth 3Y13.2%
OM growth 5Y5.69%
PM growth 3Y15.92%
PM growth 5Y6.5%
GM growth 3Y-0.37%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.63
Debt/EBITDA 0
Cap/Depr 48.66%
Cap/Sales 3.65%
Interest Coverage 250
Cash Conversion 110.69%
Profit Quality 165.59%
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z N/A
F-Score7
WACC8.92%
ROIC/WACC1.18
Cap/Depr(3y)48.45%
Cap/Depr(5y)43.32%
Cap/Sales(3y)3.65%
Cap/Sales(5y)3.66%
Profit Quality(3y)152.49%
Profit Quality(5y)173.45%
High Growth Momentum
Growth
EPS 1Y (TTM)26.51%
EPS 3Y19.48%
EPS 5Y15.93%
EPS Q2Q%27.97%
EPS Next Y12.13%
EPS Next 2Y10.63%
EPS Next 3Y10.77%
EPS Next 5YN/A
Revenue 1Y (TTM)15.05%
Revenue growth 3Y12.5%
Revenue growth 5Y11.69%
Sales Q2Q%15.79%
Revenue Next Year7.07%
Revenue Next 2Y7.14%
Revenue Next 3Y8.25%
Revenue Next 5YN/A
EBIT growth 1Y21.81%
EBIT growth 3Y27.35%
EBIT growth 5Y18.04%
EBIT Next Year24.07%
EBIT Next 3Y17.76%
EBIT Next 5YN/A
FCF growth 1Y53.56%
FCF growth 3Y22.92%
FCF growth 5Y18.61%
OCF growth 1Y48.31%
OCF growth 3Y21.71%
OCF growth 5Y17.35%